Construction and Engineering

GMF released FY2025 Q4 earnings on April 27 After-Market (BJT), actual revenue CNY 323.78 M, actual EPS CNY -0.139

GMF released FY2026 Q1 earnings on April 27 After-Market (BJT), actual revenue CNY 257.39 M, actual EPS CNY -0.0021

GMF released FY2025 Annual Earnings on April 27 After-Market (BJT), Actual Revenue: CNY 1.077 B, Actual EPS: CNY -0.17

GMF FY2026 Q1 Earning Release on April 28 After-Market (BJT)

GMF to Release FY2025 Annual Earnings on April 28, 2026 After-Market (BJT)

GMF released FY2025 9 Months Earnings on October 27 After-Market BJT, actual revenue CNY 753.52 M, actual EPS CNY -0.0378

GMF released FY2025 Q3 earnings on October 27 After-Market (BJT), actual revenue CNY 225.48 M, actual EPS CNY -0.0323

GMF to Release FY2025 Q3 Earnings on October 28 After-Market (BJT)

GMF released FY2025 Q2 earnings on August 25 During-Market (BJT), actual revenue CNY 248.3 M, actual EPS CNY -0.0219

GMF released FY2025 Semi-Annual earnings on August 25 During-Market (BJT), actual revenue CNY 528.04 M, actual EPS CNY -0.0092

GMF to Release FY2025 Semi-Annual Earnings on August 26, 2025 (BJT)

Shangrong Medical Expected to Report Loss in First Half of 2025

Shangrong Medical Fully Holds Two Newly Established Companies

Shangrong Medical Responds to Stock Price Drop and Quality Questions

Company's 2024 Performance Growth and Business Layout

Shangrong Medical's overseas revenue in 2024 is 932 million yuan

Shangrong Medical Announces 114.97% YoY Net Profit Growth in 2024

Shangrong Medical reports Q1 2025 revenue and net profit growth

GMF released FY2024 Q4 earnings on April 28 After-Market (BJT), actual revenue CNY 445.57 M, actual EPS CNY 0.0075

GMF released FY2025 Q1 earnings on April 28 After-Market (BJT), actual revenue CNY 279.74 M, actual EPS CNY 0.0165

AIRE

A reorganization is anticipated to strengthen the return-focused spending strategy, bring back certain operational functions to the local market, and empower a streamlined workforce to utilize advanced AI tools to cut costs and speed up processes. The restructuring aims at enhancing the return-driven spending approach, reintroducing specific operational roles to the local market, and empowering a smaller team to utilize innovative AI technology for cost reduction and faster execution.

Unusual Whales

reAlpha Tech

reAlpha Reduces Workforce by Approximately 25% and Consolidates Vendor Spend, Targeting $2 Million in Annualized Savings as AI Advancements Drive Organizational Efficiency

James Rickards discusses the current global turmoil, highlighting the ongoing wars, soaring energy prices, and high inflation. Despite these challenges, U.S. stock indices are near all-time highs, driven by factors like the AI boom, passive investing, and fear of missing out (FOMO). However, he warns of unrecognized risks, particularly from the war in Iran and supply chain disruptions, which could lead to a global recession. The article emphasizes that while corporate profits are strong, the market may be underestimating the impact of these geopolitical issues.

ZeroHedge

Microsoft

Amazon

Alphabet

Alphabet - C

Meta Platforms

Rickards: Investing In A World In Turmoil

The life sciences industry is at an inflection point with AI and ML moving beyond pilot stages to become integral in R&D, clinical operations, and manufacturing. McKinsey estimates generative AI could unlock $60-$110 billion annually for pharmaceuticals. However, only 5% of organizations see it as a competitive advantage. The shift from isolated ML projects to enterprise AI operating layers is crucial, emphasizing governance and integration. Classical ML remains vital for regulated workflows, while generative AI enhances regulatory and operational efficiency.

Pharmexec

<![CDATA[Industrializing Machine Learning and Artificial Intelligence in Life Sciences]]>

002551

GMF announced that its revenue for the third quarter was 225 million yuan, a decrease of 39.25%; the net profit loss was 27.367 million yuan, a decrease of 4,004.28%. Revenue for the first three quarters was 754 million yuan, a decrease of 24.85%; the net profit loss was 35.1253 million yuan, a decrease of 338.50%

Zhitong

GMF: Net profit loss of 27.367 million yuan in the third quarter, a decrease of 4,004.28%

688108

399006

On August 8th, at the midday close, the three major indices rose slightly, with the Shanghai Composite Index up 0.07%, the Shenzhen Component Index up 0.14%, and the ChiNext Index up 0.21%. The Yajiang hydropower concept stocks performed strongly, with multiple stocks hitting the daily limit; the commercial aerospace and medical device sectors were also active, with SINOMED and GMF hitting the daily limit. In contrast, AI intelligent body concept stocks adjusted, with Jinxiandai and Dingjie Shuzhi falling over 10%. Overall, the market saw more stocks decline than rise, with a total turnover of 1.09 trillion

Wallstreetcn

SINOMED

ChiNext

August 8th Midday Review: ChiNext Index rose 0.21% in half a day, and the Yajiang Hydropower concept collectively strengthened

600530

The healthcare sector is rising, GMF has hit the limit up, JIAODA ONLLY previously hit the limit up, and BGI Genomics, Anbiping, and Dian Diagnostics are among the top gainers

JIAODA ONLLY

LBP Medicine

Dian Diagnostics

BGI Genomics

The healthcare sector rises, GMF and JIAODA ONLLY hit the daily limit

300942

300633

300981

300676

The healthcare sector surged, with GMF hitting the limit up, followed by JIAODA ONLLY, SONOSCAPE, ZHYL, BGI Genomics, and Bioeasy among the top gainers

Bioeasy

SONOSCAPE

ZHYL

The healthcare sector rises, GMF hits the limit up

GMF announced that the operating revenue for 2024 is expected to be 1.448 billion yuan, a year-on-year increase of 21.40%. The net profit attributable to shareholders of the listed company is 22.282 million yuan, a year-on-year increase of 114.97%. The basic earnings per share is 0.0264 yuan/share. The company plans to distribute a cash dividend of 0.08 yuan for every 10 shares to all shareholders, with no bonus shares issued and no capital reserve converted into share capital

GMF: In 2024, the net profit is 22.282 million yuan, a year-on-year increase of 114.97%

GMF announced that its operating revenue in the first quarter of 2025 was 280 million yuan, a year-on-year increase of 1.30%. The net profit was 13.9642 million yuan, a year-on-year increase of 0.58%

GMF: In the first quarter of 2025, the net profit was 13.9642 million yuan, a year-on-year increase of 0.58%

GMF released its 2024 performance forecast, expecting a net profit of between 23 million yuan and 34.5 million yuan, turning a profit compared to the previous year. The company has reduced management expenses by approximately 30 million yuan and asset impairment losses by about 60 million yuan through strengthened internal management and cost control. The expected operating revenue is 1.3 billion yuan, an increase of 111 million yuan compared to the same period last year, mainly due to the good progress of engineering projects

GMF issued a profit warning, expecting a net profit of 23 million to 34.5 million yuan for the fiscal year 2024, turning a profit compared to the same period last year

GMF(002551.SZ)